SPINK1 or tumor-associated trypsin inhibitor (TATI) did not appear to be a good tumor marker in lung cancer, since its sensitivity was poor and the correlation between TATI serum levels and stage of the disease and histological type was weak [34]. Here, SPINK1 is linked to lung cancer.